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Male Cr 2 1 .l mg/dl 
Female Crk0.9 mg/dl 
Age 
Hypertension 
Diabetes 
High Cholesterol 
Smoking 
Family History 
Table 
Odds Ratio 
3.64 
0.62 
1.05 
2.27 
1.57 
0.94 
1.36 
1.17 
P Value 
0.0003 
0.56 
0.0001 
0.04 
0.11 
0.82 
0.25 
0.61 
1020-36 SPECT Myocardial Perfusion Imaging in Women: How 
Critical Is Choice of Radionuclide for Attaining Optimal 
Results? 
Timothv M. Bateman, Frans J. Th. Wackers, Jennifer H. Mieres, S. James Cullom, Kelly 
L. Moutray, Ginger K. Hertenstein, Nicole A. Nichols, James A. Case, Mid-America Heart 
Institute, Kansas City, MO 
Introduction: No data exists comparing relative accuracy of gated thallium-201 (TI) and 
Tc-99m sestamibi (MIBI) SPECT myocardial perfusion imaging in women. As such, it is 
not known if radionuclide selection is important for attaining optimal results in women. 
Methods: Randomly presented grated and non-g&ad SPECT scans (total 636) of 316 
women (209 with cath < 60 days - 43 OVD. 56 1VD. 60 ZVD, 46 3VD; 109 ~5% CAD like- 
lihood) acquired at 3 different centers were read blindedly by consensus of 3 experi- 
enced readers. The studies (159 TI-201, 159 MIBI) were assessed for quality (good, 
average, poor), % interpreted as definitely normal or abnormal, and interpretation for 
each coronary territory. Studies were acquired from 1997 to 2002 using ASNC standard 
procedures. 56% were performed with exercise and 44% with pharmacologic stress. 
Exclusionary criteria were prior CABG or transplant or recent PCI. Results: Image qual- 
ity was rated good for 92% TI and 90% MIBI images. See Table (criteria for CAD z-69% 
luminal narrowing): 
Diag Certainty CAD Accuracy Cor Terntory Act Normalcy 
Tl (no gate) 63% 69% 70% 78% 
TI (gated) 93% 66% 70% 94% 
MIBI (no gate) 66% 77% 70% 64% 
MIBI (gated) 05% 74% 70% 87% 
Conclusions: This large blinded read demonstrates high image quality and diagnostic 
accuracy independent of whether radionuclide employed is thallium-201 or Tc-99m ses- 
tamibi. For both agents, ECG-gating is useful as it improves diagnostic certainty and 
reduces false positive scans. 
1020-39 Prognostic Value of a Normal Stress Myocardial 
Perfusion Study in African-American, Hispanic, and 
White Patients 
Olakunle 0. Akinbobove. Kati Berekashvili, Steven R. Bergmann, Theodore Addai. 
Columbia University, New York, NY, Saint Francis Hospital, Roslyn, NY 
Previous studies have shown that major cardiovascular events (death or MI) occur in 
approximately 1% of patients following a normal stress myocardial perfusion study. HOW- 
aver, it is not known if there are racial or gender differences in event-free survival after a 
normal stress perfusion study. We prospectively followed 769 consecutive patients, 
including 265 Hispanic (F=173 ), 266 Caucasian (F= 119)and 236 African-American 
(F=152) patients, who had a normal gated SPECT dual isotope myocardial perfusion 
study in our laboratory between January of 1999 and December of 2000. Treadmill exer- 
cise was perfomled in 57%. and the remainder underwent pharmacological stress. The 
mean duration of follow-up was 11 Q months and follow-up was complete in 97% of the 
population. Follow-up was performed by reviewing medical records and social security 
index database, and conducting scripted patient and physician interviews. Kaplan-Meier 
survival analysis was performed and outcomes in gender and race cohorts were com- 
pared using Wilcoxon statistic. There was no significant difference in survival between 
the 3 race cohorts. Sub-group analysis did not show any gender difference in survival in 
the 3 race cohorts. 
Conclusrons: There is no racial or gender difference rn major cardiovascular event-free 
survival after a normal stress perfusion study. 
Survival Analysis by Race 
n age Death or Ml Survival (%) 
Hispamcs 265 60+/- 13 1 99.6 
African-Americans 236 60+/- 13 2 99.1 
Caucasians 208 63+/-13 3 96.7 
Wilcoxon Statistic ns 
1020-40 Low-Dose Dobutamina Gated SPECT to Predict 
Improvement in Left Ventricular Ejection Fraction in 
Patients Wlth lschemic Cardiomyopathy Treated With 
Beta-Blocker Therapy 
Eric P. Vierawer, Ernst E. van der Wall, Geesje Abels. Guido Germane, Daniel S. 
Berman. Jeroen J. Bax. Greene Had Medical Center, Gouda. The Netherlands. Leiden 
University Medical Center, Leiden, The Netherlands 
Background: Beta-blocker therapy has been demonstrated to improve LVEF in patients 
with lschemic cardiomyopathy, although not all patients respond equally well. The mech- 
anism underlying the response to beta-blocker therapy is unknown. We hypothesized 
that the response to beta-blocker therapy may be related to the presence of contractile 
reserve in patients with hibernating myocardium. 
Methods: 25 patients with ischemic cardiomyopathy (LVEF ~40%) underwent rest and 
low-dose (10 mcgikg/min) dobutamine gated SPECT (usrng Tc99m-tetrofosmin). From 
these data, LVEF was assessed at rest and during low-dose dobutamine infusion. The 
presence of global contractile reserve was considered present when LVEF increased 
~7% during low-dose dobutamine. 
Patients were treated for 3-6 months with beta-blockers (Carvedilol, max dose 50 mg 
daily), and thereafter restrng gated SPECT was repeated to evaluate response to ther- 
apy. An increase ~-7% in LVEF was considered significant. 
Results: Contractile reserve was present in 14 patients; in these patients, the LVEF 
increased from 31+7% to 42+6% (PcO.05) during low-dose dobutamine gated SPECT. 
Of these, 11 (79%) improved in LVEF (from 31+7% to 39*9%. PcO.05) following 3-6 
months beta-blocker therapy. Conversely, 11 patients did not exhibit contractile reserve 
(LVEF 26a9% at baseline, 27+10% during low-dose dobutamine); of these, 10 (91%) did 
not improve in LVEF after beta-blocker therapy. Considering an improvement in LVEF 
~-7% as a predictor for response to beta-blocker therapy, low-dose dobutamine gated 
SPECT had a positive predictive value of 79% and a negative predictive value of 91% to 
predict response to beta-blocker therapy. 
Conclusion: Contractile reserve during low-dose dobutamine gated SPECT can predict 
improvement in LVEF after beta-blocker therapy. 
1020-41 incremental Prognostic Value of Left Ventricular 
Function by Gated SPECT Over Perfusion Imaging in 
Patients Undergoing Dobutamine Stress Myocardial 
Perfusion Imaging 
Sachin M. Navare, Michael S. Fowler, Lynne L. Johnson, Deborah Katten. Jeff F. Mather, 
Letitia L. Anderson, Gary V. Heller. Hartford Hospital, Hartford, CT, Rhode Island 
Hospital, Providence, RI 
Background: Recent data has shown that patients referred for Dobutamine Stress Myo- 
cardial Perfusion Imaging (DSMPI) are a high risk population. Both the ECG response 
and the type and extent of perfusion defects during DSMPI have significant predictive 
value while risk stratifying these patients. However the value of left ventricular function as 
assessed by gated single photon emission computed tomography (SPECT) during 
DSMPI is unknown. Methods: We identified 647 consecubve patients who underwent 
DSMPI because of inability to perform adequate exercise. Perfusfon images were classi- 
fied as normal or abnormal (fixed or reversible defects) while left ventricular function as 
derived from gated SPECT was defined as preserved (ejection fraction [EF] 145%) or 
impaired (EF < 45%). Follow-up was complete in 96% of patients (mean 21 months). 
Results: Annual cardrac event (myocardial infarction and cardiac death) rates with nor- 
mal and abnormal perfusion images were 2.2 % and 6.6 % (p < 0.01) respectwely. Srmi- 
larly patients with EF > 45% had annual event rate of 2.6 % Vs 10.9 % (p < 0.01) with EF 
< 45%. Addition of EF further risk stratified patients with abnormal SPECT images. In 
patients with abnormal SPECT, EF > 45% predicted a significantly better survival than 
EF < 45%. 
Conclusions: Assessment of left ventricular function by gated-SPECT during DSMPI 
has incremental prognostic value over information provided by perfusion alone and iden- 
tifies a subgroup of patients with abnormal perfusion who have a better prognosis. 
